For more information or confidential assistance
800-306-3180
se habla español

Dawn Snyder

Dawn Snyder is a well-rounded litigator and legal writer with a solo practice. She is a regular contributor to Drug Reporter.

FDA Approval of Xarelto May Have Been Based on False Data

Thousands of Xarelto users have brought federal lawsuits against the drug’s manufacturers alleging that the anticoagulant caused uncontrollable bleeding and severe injuries. Recent reports shed light on a how the drug made it to the market with FDA approval. The anticoagulant’s drug trial was based on what may have been a... Read more »

20 Year-old Woman Files Zofran Complaint

A 20-year-old woman has filed a Zofran lawsuit in California. The case seeks to hold defendants GlaxoSmithKline and McKesson Corporation responsible for the birth defects that the plaintiff suffered after her mother took Zofran during pregnancy. The Texas woman filed her complaint in the United States District Court for the Northern District of... Read more »

Kentucky Plaintiffs Blame Zofran for Newborn Death

A Kentucky couple has filed a Zofran lawsuit against manufacturer GlaxoSmithKline, LLC (GSK) over the death of their son. The lawsuit also names Hospira, Inc., and Pfizer, Inc., makers of the generic form of the drug, as defendants. The lawsuit was filed on September 30, 2015, in the United States... Read more »

Actos Lawsuits Headed for Mass Settlement

According to a recent announcement by Actos manufacturer Takeda Pharmaceuticals, over 96 percent of the eligible claimants have agreed to take part in the Actos product liability resolution program. Through the program, over 9,000 plaintiffs may receive compensation for their injuries without the uncertainty that exists in continued litigation. With over... Read more »

Xarelto Internal Bleeding Lawsuit Adds 5 Plaintiffs to MDL

On August 7, 2015, five plaintiffs from as many states filed a joint complaint adding a Xarelto internal bleeding lawsuit to ongoing multi-district litigation (“MDL”). There are more than 500 Xarelto lawsuits already included in the MDL. The complex litigation is being overseen by U.S. District Judge Eldon Fallon in... Read more »

Federal Judge Orders Coordination with State Actos Lawsuits

The federal judge presiding over thousands of Actos lawsuits that are currently consolidated in a multi-district litigation (MDL) recently issued a handful of case management orders. The orders are an apparent attempt to streamline the large, complex litigation, encourage large-scale settlement, and prevent duplication of thousands of state court Actos... Read more »

Xarelto Lawsuits May Be Headed For MDL

Plaintiffs across the country have filed at least 21 Xarelto lawsuits against the maker of the popular blood thinner. The product liability lawsuits have been filed in 10 separate federal district courts. A group of the federal plaintiffs have now filed a motion for transfer requesting that the U.S. Judicial... Read more »

PA Woman Nets $2 Million Actos Lawsuit Award

Earlier this month, a 79-year-old Philadelphia woman received a $2 million Actos lawsuit award for her bladder cancer claim. The jurors, after deliberating for more than five hours, found that the manufacturer was liable for Frances Wisniewski’s bladder cancer because it failed to warn her doctors about the cancer risk.... Read more »

Study Finds Link Between Benicar and Celiac Like Symptoms

Benicar label
Celiac disease has been mysteriously on the rise in recent years but a new study has linked some celiac-like symptoms with the use of olmesartan, a popular blood pressure medication commonly sold under the name Benicar. Benicar is a hypertension medication also known under the generic name olmesartan. It is an angiotensin II receptor... Read more »